News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 2728
- Sources here
- 18
- Companies here
- 24
Search results
Stored financial headlines
Active search
2728 matching headlines
Ticker or company: ARAMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Following Yara International and Nutrien's Expansion in Fertigation and Water-Soluble Formulations, New Study Projects 7.8% CAGR for Specialty Fertilizers
Company Logo This study delivers an in-depth evaluation across technology categories (water-soluble fertilizers, controlled-release fertilizers, slow-release fertilizers, micronutrients, liquid formulations), application methods (fertigation, foliar, soil), crop types (fruits & vegetables, cereals & grains, oilseeds), and regional growth drivers dominated by the Asia-Pacific region. Specialty …
YAR
main company
Sharemaestro market context
Price below Trend Line
52 weeks +16.5%
Aramark Destinations Welcomes the Changing Seasons with Signature Travel Experiences
Aramark Destinations is celebrating the changing seasons by offering unique travel experiences. The company aims to provide memorable and signature adventures for its guests. This initiative highlights Aramark's commitment to seasonal programming and diverse recreational opportunities.
ARMK
main company
Sharemaestro market context
Trend signal active
52 weeks +57.1%
Dimensional Fund Advisors LP Increases Stock Position in Bicara Therapeutics Inc. $BCAX
Dimensional Fund Advisors LP significantly increased its stake in Bicara Therapeutics Inc. by 166.9% in the first quarter, now holding 109,261 shares valued at $2.17 million. Several other institutional investors also raised their positions, while insider sales have occurred. Bicara Therapeutics maintains a "Moderate …
BCAX
main company
Sharemaestro market context
Trend signal active
52 weeks +105.1%
Dimensional Fund Advisors LP Grows Stock Holdings in Protara Therapeutics, Inc. $TARA
Dimensional Fund Advisors LP significantly increased its stake in Protara Therapeutics, Inc. (NASDAQ:TARA) by 133.9% in the first quarter, now holding over 531,000 shares valued at $2.77 million. Other institutional investors have also adjusted their holdings, with hedge funds and institutions collectively owning 38.13% …
TARA
main company
Sharemaestro market context
Price below Trend Line
52 weeks +27.7% · Next-week setup negative 44.5%
Samsara’s 38% quarter outruns software peers, while volume still lags the rebound
IOT added 9.7% for the week and closed 27.5% above its weekly Trend Line, but the latest 23.1M-share volume leaves participation short of full confirmation.
IOT
main company
Sharemaestro market context
Trend signal active
52 weeks +14.4%
AFARAK GROUP: INTERIM REPORT H1 2026
Afarak Group SE 07:00 London, 09:00 Helsinki, 14 August 2026 - Afarak Group SE ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR) FINANCIAL INTERIM RELEASE H1 2026 H1/26 H1/25 2025 Revenue EUR million 57.1 77.1 141.3 EBITDA EUR million 1.6 6.9 -0.2 EBIT EUR …
AFAGR
main company
Sharemaestro market context
Price below Trend Line
52 weeks -15.0% · Next-week setup negative 38.7%
Parabilis Medicines (PBLS) boosts cash above $1.1B after IPO and Regeneron deal
Parabilis Medicines, Inc. reported its Q2 2026 results, showing a significant increase in cash and cash equivalents to over $1.1 billion. This boost follows its June 2026 IPO, which generated $787.9 million in net proceeds, and a $50.0 million upfront payment from its collaboration …
PBLS
main company
Sharemaestro market context
Stored weekly price path
10 weeks +36.0% · Next-week setup positive 76.4%
Sanara MedTech (SMTI) Stock Stays Quiet As Profitability Meets Debt Scrutiny
Sanara MedTech (SMTI) recently turned profitable in Q2 2026, reporting net income of US$0.40m from continuing operations, a significant improvement from a loss in the prior year. Despite this positive shift and increased revenue, the stock's reaction was muted, with concerns remaining over thin …
SMTI
main company
Sharemaestro market context
Trend signal active
52 weeks +0.6% · Next-week setup negative 41.2%
Paramount just offered up its crown jewel
When regulators threaten to block a merger, the company on the other side usually offers something replaceable. A distribution deal. A regional station. A slice of market share nobody will miss. Paramount Skydance just put its most recognizable news brand on the table instead. …
Sharemaestro market context Price below Trend Line 52 weeks -42.0% · Next-week setup negative 31.3%Form 8K Parabilis Medicines For: 13 August By Investing.com
The article is a brief financial news item from Investing.com, reporting on a Form 8K filing by Parabilis Medicines for August 13th. It provides no further details beyond stating the filing occurred on that date.
PBLS
main company
Sharemaestro market context
Stored weekly price path
10 weeks +36.0% · Next-week setup positive 76.4%
Earnings Flash (PBLS) Parabilis Medicines, Inc. Reports Q2 Revenue $148,000
Parabilis Medicines, Inc. (PBLS) reported its Q2 revenue as $148,000. The company, a clinical-stage biopharmaceutical firm, focuses on developing transformative medicines for "undruggable" protein targets using its proprietary Helicon platform. Analysts currently have a "BUY" consensus for PBLS with an average target price of …
PBLS
main company
Sharemaestro market context
Stored weekly price path
10 weeks +36.0% · Next-week setup positive 76.4%
Overnight at Red Rocks: Aramark Races the Clock to Reset an Iconic Venue
This article focuses on Aramark's logistical challenges and operational prowess in managing the rapid turnovers required at the iconic Red Rocks Amphitheatre. It highlights the tight schedules and coordination needed to reset the venue overnight between major events. The piece likely details the various …
ARMK
main company
Sharemaestro market context
Trend signal active
52 weeks +57.1%
ARMK Q2 Deep Dive: Nexus Expansion and Core Business Growth Drive Momentum
ARMK Q2 Deep Dive: Nexus Expansion and Core Business Growth Drive Momentum Food and facilities services provider Aramark (NYSE:ARMK) reported revenue ahead of Wall Street's expectations in Q2 CY2026, with sales up 9.3% year on year to $5.06 billion. Its non-GAAP profit of $0.52 …
ARMK
main company
Sharemaestro market context
Trend signal active
52 weeks +57.1%